A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma

被引:12
作者
Chen, Ji [1 ]
Zhan, Yating [1 ]
Zhang, Rongrong [1 ]
Chen, Bo [1 ]
Huang, Junting [1 ]
Li, Chunxue [1 ]
Zhang, Wenjie [1 ]
Wang, Yajing [1 ]
Gao, Yuxiang [1 ]
Zheng, Jianjian [1 ]
Li, Yeping [2 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Diag & Treatment Severe Hepatopancreat Di, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Dept Urol, Affiliated Hosp 1, Wenzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
TCGA database; ferroptosis; ccRCC; prognosis signature; immune infiltration; T-CELLS; CANCER; MODEL; PROGRESSION; SUPPRESSES;
D O I
10.3389/fonc.2021.700084
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clear cell renal cell carcinoma (ccRCC) is the most common renal cell carcinoma and has poor prognosis in the locally advanced stage. Ferroptosis, a relatively new type of cell death, has gained significant attention in recent years. This study aimed to explore the prognostic value of ferroptosis-related genes (FRGs) in ccRCC. In this study, 50 differentially expressed FRGs between ccRCC and adjacent normal kidney tissues were identified, 26 of them correlated with overall survival (OS) (P <0.05). Eight optimal FRGs were selected by Lasso regression and multivariate Cox regression analysis, and used to construct a new prognostic risk signature to predict the prognosis of ccRCC patients. In addition, the signature passed the validation of prognostic survival analyses by a significant margin, and the risk score was identified as an independent prognostic marker via Cox regression analyses. Further studies indicated that the signature was significantly correlated with immune cell infiltration. Moreover, the levels of eight FRGs were examined in ccRCC. Collectively, the 8-FRG prognostic risk signature helps the clinicians predict the prognosis and OS of the patients, and standardize prognostic assessments.
引用
收藏
页数:14
相关论文
共 41 条
[1]   Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy [J].
Bai, Dan ;
Feng, Huhu ;
Yang, Jiajun ;
Yin, Aiping ;
Qian, Airong ;
Sugiyama, Hiroshi .
CANCER SCIENCE, 2021, 112 (06) :2126-2139
[2]   ImmPort: disseminating data to the public for the future of immunology [J].
Bhattacharya, Sanchita ;
Andorf, Sandra ;
Gomes, Linda ;
Dunn, Patrick ;
Schaefer, Henry ;
Pontius, Joan ;
Berger, Patty ;
Desborough, Vince ;
Smith, Tom ;
Campbell, John ;
Thomson, Elizabeth ;
Monteiro, Ruth ;
Guimaraes, Patricia ;
Walters, Bryan ;
Wiser, Jeff ;
Butte, Atul J. .
IMMUNOLOGIC RESEARCH, 2014, 58 (2-3) :234-239
[3]   Renal cancer [J].
Capitanio, Umberto ;
Montorsi, Francesco .
LANCET, 2016, 387 (10021) :894-906
[4]   Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma br [J].
Chakiryan, Nicholas H. ;
Hajiran, Ali ;
Kim, Youngchul ;
Aydin, Ahmet M. ;
Zemp, Logan ;
Katende, Esther ;
Nguyen, Jonathan ;
Fan, Wenyi ;
Cheng, Chia -Ho ;
-Blanco, Neale Lopez ;
Chahoud, Jad ;
Spiess, Philippe E. ;
Fournier, Michelle ;
Dhillon, Jasreman ;
Wang, Liang ;
Moran-Segura, Carlos ;
Mule, James ;
Du, Dongliang ;
Yoder, Sean J. ;
Berglund, Anders ;
Teer, Jamie K. ;
Manley, Brandon J. .
EUROPEAN UROLOGY FOCUS, 2022, 8 (03) :784-793
[5]   AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent manner [J].
Chang, Lin-lin ;
Li, Yue-kang ;
Zhao, Chen-xi ;
Zeng, Chen-ming ;
Ge, Fu-jing ;
Du, Jia-min ;
Zhang, Wen-zhou ;
Lu, Pei-hua ;
He, Qiao-jun ;
Zhu, Hong ;
Yang, Bo .
ACTA PHARMACOLOGICA SINICA, 2022, 43 (03) :703-711
[6]   The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma [J].
Cho, Sung Hwan ;
Pak, Kyoungjune ;
Jeong, Dae Cheon ;
Han, Myoung-Eun ;
Oh, Sae-Ock ;
Kim, Yun Hak .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) :4140-4146
[7]   Identification of novel epigenetic markers for clear cell renal cell carcinoma [J].
Dalgin, Gul S. ;
Drever, Michele ;
Williams, Tara ;
King, Thomas ;
DeLisi, Charles ;
Liou, Louis S. .
JOURNAL OF UROLOGY, 2008, 180 (03) :1126-1130
[8]   Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s [J].
Daugan, Marie V. ;
Revel, Margot ;
Russick, Jules ;
Dragon-Durey, Marie-Agnes ;
Gaboriaud, Christine ;
Robe-Rybkine, Tania ;
Poillerat, Victoria ;
Grunenwald, Anne ;
Lacroix, Guillaume ;
Bougouin, Antoine ;
Meylan, Maxime ;
Verkarre, Virginie ;
Oudard, Stephane M. ;
Mejean, Arnaud ;
Vano, Yann A. ;
Perkins, Geraldine ;
Validire, Pierre ;
Cathelineau, Xavier ;
Sanchez-Salas, Rafael ;
Damotte, Diane ;
Fremeaux-Bacchi, Veronique ;
Cremer, Isabelle ;
Sautes-Fridman, Catherine ;
Fridman, Wolf H. ;
Roumenina, Lubka T. .
CANCER IMMUNOLOGY RESEARCH, 2021, 9 (08) :891-908
[9]   Adjuvant Treatment for High-Risk Clear Cell Renal Cancer Updated Results of a High-Risk Subset of the ASSURE Randomized Trial [J].
Haas, Naomi B. ;
Manola, Judith ;
Dutcher, Janice P. ;
Flaherty, Keith T. ;
Uzzo, Robert G. ;
Atkins, Michael B. ;
DiPaola, Robert S. ;
Choueiri, Toni K. .
JAMA ONCOLOGY, 2017, 3 (09) :1249-1252
[10]   SAC3D1: a novel prognostic marker in hepatocellular carcinoma [J].
Han, Myoung-Eun ;
Kim, Ji-Young ;
Kim, Ga Hyun ;
Park, Siyoung ;
Kim, Yun Hak ;
Oh, Sae-Ock .
SCIENTIFIC REPORTS, 2018, 8